Nifty
Sensex
:
:
11661.85
39298.38
75.50 (0.65%)
246.32 (0.63%)

Pharmaceuticals & Drugs

Rating :
40/99

BSE: 526953 | NSE: VENUSREM

34.30
18-Oct-2019
  • Open
  • High
  • Low
  • Previous Close
  •  33.85
  •  35.30
  •  30.95
  •  29.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  630049
  •  207.79
  •  68.00
  •  18.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 42.21
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 337.39
  • N/A
  • 0.13

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.89%
  • 2.98%
  • 52.56%
  • FII
  • DII
  • Others
  • 1.47%
  • 0.00%
  • 7.10%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.31
  • -7.75
  • -7.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.46
  • -16.98
  • -6.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.23

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.40
  • 3.91
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.40
  • 0.25
  • 0.20

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.30
  • 6.09
  • 6.48

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
73.65
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
63.86
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
9.78
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
13.28%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.82
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
6.18
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
8.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
-4.07
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
-4.07
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
-5.53%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
-3.30
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
321.89
372.41
400.04
418.27
463.99
541.56
468.64
409.84
363.09
314.03
Net Sales Growth
-
-13.57%
-6.91%
-4.36%
-9.85%
-14.32%
15.56%
14.35%
12.88%
15.62%
 
Cost Of Goods Sold
-
181.95
205.08
227.07
238.51
268.94
300.00
262.26
225.91
201.50
182.31
Gross Profit
-
139.94
167.33
172.97
179.77
195.05
241.55
206.38
183.92
161.59
131.71
GP Margin
-
43.47%
44.93%
43.24%
42.98%
42.04%
44.60%
44.04%
44.88%
44.50%
41.94%
Total Expenditure
-
289.37
332.94
349.32
337.11
374.81
403.33
348.53
306.96
273.00
241.27
Power & Fuel Cost
-
4.86
4.29
4.14
4.01
3.80
3.38
3.05
2.71
2.72
1.72
% Of Sales
-
1.51%
1.15%
1.03%
0.96%
0.82%
0.62%
0.65%
0.66%
0.75%
0.55%
Employee Cost
-
42.10
39.31
34.27
32.44
32.36
30.45
27.30
24.83
20.38
16.72
% Of Sales
-
13.08%
10.56%
8.57%
7.76%
6.97%
5.62%
5.83%
6.06%
5.61%
5.32%
Manufacturing Exp.
-
21.01
36.10
42.48
15.70
17.29
22.10
20.61
18.18
17.05
14.70
% Of Sales
-
6.53%
9.69%
10.62%
3.75%
3.73%
4.08%
4.40%
4.44%
4.70%
4.68%
General & Admin Exp.
-
11.85
13.52
13.26
11.97
15.67
14.74
11.82
12.14
11.54
9.13
% Of Sales
-
3.68%
3.63%
3.31%
2.86%
3.38%
2.72%
2.52%
2.96%
3.18%
2.91%
Selling & Distn. Exp.
-
27.60
34.65
28.10
34.48
36.75
32.65
23.50
22.98
19.82
15.28
% Of Sales
-
8.57%
9.30%
7.02%
8.24%
7.92%
6.03%
5.01%
5.61%
5.46%
4.87%
Miscellaneous Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.20
0.00
15.28
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0.05%
0%
0.45%
EBITDA
-
32.52
39.47
50.72
81.16
89.18
138.23
120.11
102.88
90.09
72.76
EBITDA Margin
-
10.10%
10.60%
12.68%
19.40%
19.22%
25.52%
25.63%
25.10%
24.81%
23.17%
Other Income
-
6.09
2.39
4.28
2.01
0.68
0.47
0.44
0.49
0.40
0.16
Interest
-
25.41
35.56
36.38
37.98
41.21
29.40
24.63
27.49
18.86
14.07
Depreciation
-
33.98
33.83
40.26
41.68
46.00
40.22
33.08
25.02
18.98
12.47
PBT
-
-20.77
-27.53
-21.64
3.51
2.65
69.08
62.84
50.85
52.63
46.38
Tax
-
-1.15
3.16
-4.56
1.81
-2.51
4.78
5.53
3.78
6.41
6.82
Tax Rate
-
3.87%
-11.48%
21.07%
51.57%
-94.72%
6.92%
8.80%
7.43%
12.18%
14.70%
PAT
-
-28.57
-30.69
-17.08
1.70
5.16
64.30
57.31
47.08
46.22
39.56
PAT before Minority Interest
-
-28.57
-30.69
-17.08
1.70
5.16
64.30
57.31
47.08
46.22
39.56
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
-8.88%
-8.24%
-4.27%
0.41%
1.11%
11.87%
12.23%
11.49%
12.73%
12.60%
PAT Growth
-
-
-
-
-67.05%
-91.98%
12.20%
21.73%
1.86%
16.84%
 
Unadjusted EPS
-
-23.15
-24.87
-14.88
1.48
4.51
57.17
58.80
51.22
50.62
46.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
332.52
361.91
388.67
437.62
456.68
461.61
379.13
307.29
236.92
171.18
Share Capital
12.34
12.34
12.34
11.44
11.44
11.44
10.54
9.74
9.13
8.47
Total Reserves
320.18
349.57
376.33
426.18
445.24
450.17
363.81
288.53
223.59
160.58
Non-Current Liabilities
136.68
158.47
179.52
212.05
221.55
161.75
147.18
113.51
99.41
156.96
Secured Loans
61.29
86.60
112.69
134.57
150.95
114.76
103.89
75.45
65.97
91.67
Unsecured Loans
54.73
50.84
49.13
56.47
51.34
25.22
25.22
23.68
22.02
57.73
Long Term Provisions
5.32
4.50
4.29
3.79
3.78
3.31
2.91
2.50
1.94
0.00
Current Liabilities
263.62
230.47
196.81
193.14
162.83
210.99
191.25
153.22
124.53
21.95
Trade Payables
36.00
29.33
29.73
25.14
29.56
31.22
18.76
12.55
7.02
6.36
Other Current Liabilities
110.30
78.56
46.16
42.71
15.96
54.70
58.18
43.44
40.07
3.48
Short Term Borrowings
112.80
121.26
119.16
123.32
115.40
110.08
95.68
83.24
63.17
0.00
Short Term Provisions
4.52
1.32
1.76
1.97
1.91
14.99
18.63
13.99
14.27
12.11
Total Liabilities
732.82
750.85
765.00
842.81
841.06
834.35
717.56
574.02
460.86
350.09
Net Block
364.45
389.20
406.18
452.48
443.65
439.46
401.42
355.39
293.28
229.50
Gross Block
707.02
703.32
686.50
679.57
641.12
587.38
511.00
430.25
343.15
260.85
Accumulated Depreciation
342.57
314.11
280.32
227.09
197.47
147.93
109.58
74.87
49.86
31.36
Non Current Assets
467.39
487.08
505.60
565.75
607.85
562.24
491.97
404.40
322.49
230.36
Capital Work in Progress
64.76
64.76
66.25
80.37
78.30
67.80
47.81
23.00
15.31
0.86
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
38.18
33.11
33.17
32.90
85.91
54.98
42.74
26.01
13.91
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
265.43
263.77
259.41
277.07
233.21
272.11
225.58
169.63
138.37
118.66
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
142.73
138.17
140.60
143.29
142.87
142.26
128.03
96.82
75.43
61.94
Sundry Debtors
38.04
47.27
47.29
61.59
63.22
64.99
47.11
40.10
35.74
28.30
Cash & Bank
2.81
3.98
3.56
7.07
3.62
4.41
6.36
2.95
3.12
2.40
Other Current Assets
81.85
0.00
0.00
0.00
23.51
60.47
44.08
29.77
24.07
26.03
Short Term Loans & Adv.
76.70
74.34
67.96
65.12
23.51
60.47
44.08
29.77
23.87
26.03
Net Current Assets
1.81
33.30
62.59
83.93
70.38
61.12
34.33
16.41
13.84
96.72
Total Assets
732.82
750.85
765.01
842.82
841.06
834.35
717.55
574.03
460.86
350.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
45.33
51.44
58.93
46.88
67.80
52.65
52.15
41.67
37.35
31.68
PBT
-29.73
-27.53
-21.64
3.51
2.65
69.08
62.84
50.85
52.63
46.38
Adjustment
60.72
66.31
70.61
56.41
83.56
37.21
40.72
29.96
24.74
12.40
Changes in Working Capital
14.33
12.66
9.96
-13.04
-18.40
-53.65
-51.41
-39.14
-40.02
-27.10
Cash after chg. in Working capital
45.33
51.44
58.93
46.88
67.80
52.65
52.15
41.67
37.35
31.68
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-11.33
-12.31
-18.32
2.92
-67.18
-94.66
-103.89
-95.15
-96.43
-51.22
Net Fixed Assets
-5.05
-11.74
18.95
-50.18
-67.39
-93.77
-101.63
-93.38
-94.69
-52.36
Net Investments
28.60
0.00
0.00
0.00
0.00
0.00
0.00
-0.37
-3.58
0.00
Others
-34.88
-0.57
-37.27
53.10
0.21
-0.89
-2.26
-1.40
1.84
1.14
Cash from Financing Activity
-35.17
-38.71
-44.13
-46.35
-1.42
40.06
55.15
53.31
59.80
20.34
Net Cash Inflow / Outflow
-1.17
0.42
-3.51
3.46
-0.79
-1.95
3.41
-0.17
0.72
0.81
Opening Cash & Equivalents
3.98
3.56
7.07
3.62
4.41
6.36
2.95
3.12
2.40
1.59
Closing Cash & Equivalent
2.81
3.98
3.56
7.07
3.62
4.41
6.36
2.95
3.12
2.40

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
269.43
293.23
314.92
382.47
399.13
403.43
355.10
306.18
254.92
198.25
ROA
-3.85%
-4.05%
-2.12%
0.20%
0.62%
8.29%
8.87%
9.10%
11.40%
12.23%
ROE
-8.23%
-8.18%
-4.13%
0.38%
1.12%
15.38%
17.04%
17.73%
23.07%
26.17%
ROCE
-0.67%
1.17%
2.00%
5.35%
5.74%
14.06%
14.85%
16.47%
19.24%
20.58%
Fixed Asset Turnover
0.46
0.54
0.59
0.63
0.76
0.99
1.00
1.06
1.20
1.34
Receivable days
48.37
46.34
49.67
54.45
50.42
37.72
33.88
33.71
32.14
35.56
Inventory Days
159.26
136.61
129.51
124.86
112.15
90.94
87.34
76.56
68.94
61.82
Payable days
37.91
30.30
26.74
26.74
27.25
21.28
15.09
11.03
8.63
10.98
Cash Conversion Cycle
169.72
152.65
152.44
152.57
135.32
107.37
106.14
99.25
92.44
86.40
Total Debt/Equity
0.90
0.85
0.80
0.77
0.70
0.63
0.72
0.74
0.80
0.89
Interest Cover
-0.17
0.23
0.41
1.09
1.06
3.35
3.55
2.85
3.79
4.30

Top Investors:

News Update:


  • Venus Remedies to sell patented product Elores to Cipla for Indian Territory
    18th Oct 2019, 10:21 AM

    This association with Cipla will enable greater patient access of Elores in India

    Read More
  • Venus Remedies - Quarterly Results
    13th Aug 2019, 18:06 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.